The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Tenet Healthcare Corp

NYSE: THC
Last

(U.S.) $13.50

Today's change+0.16 +1.20%
Updated November 22 4:03 PM EST. Delayed by at least 15 minutes.
 

Tenet Healthcare Corp

NYSE: THC
Last

(U.S.) $13.50

Today's change+0.16 +1.20%
Updated November 22 4:03 PM EST. Delayed by at least 15 minutes.

Tenet Healthcare Corp up (U.S.)$0.16

Tenet Healthcare Corp closed up Wednesday by (U.S.)$0.16 or 1.20% to (U.S.)$13.50. Over the last five days, shares have gained 2.04%, but are down 9.03% for the last year to date. Shares have underperformed the S&P 500 by 34.15% during the last year.

Key company metrics

  • Open(U.S.) $13.34
  • Previous close(U.S.) $13.34
  • High(U.S.) $13.89
  • Low(U.S.) $13.34
  • Bid / Ask-- / --
  • YTD % change-9.03%
  • Volume2,194,735
  • Average volume (10-day)2,631,872
  • Average volume (1-month)3,819,834
  • Average volume (3-month)4,288,304
  • 52-week range(U.S.) $12.25 to (U.S.) $22.72
  • Beta1.20
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward20.66×
  • Forward PEG1.11×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$5.50
Updated November 22 4:03 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-1.03%

Although this company's net profit margin is negative, it is above the industry average and implies that Tenet Healthcare Corp is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue4,5864,8024,8134,860
Total other revenue--------
Total revenue4,5864,8024,8134,860
Gross profit3,8464,0224,0484,087
Total cost of revenue740780765773
Total operating expense4,6734,5184,5464,588
Selling / general / administrative2,2642,3462,3802,324
Research & development--------
Depreciation / amortization219222221218
Interest expense (income), net operating--------
Unusual expense (income)3694523123
Other operating expenses, total1,1191,1531,1861,196
Operating income-87284267272
Interest income (expense), net non-operating-257-260-258-249
Gain (loss) on sale of assets--------
Other--------
Income before tax-34819429
Income after tax-288313723
Income tax, total-60-12-336
Net income-367-55-53-79
Total adjustments to net income--------
Net income before extra. items-366-56-52-79
Minority interest-78-87-89-102
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-366-56-52-79
Inc. avail. to common incl. extra. items-367-55-53-79
Diluted net income-367-55-53-79
Dilution adjustment--------
Diluted weighted average shares101101100100
Diluted EPS excluding extraordinary itemsvalue per share-3.63-0.56-0.52-0.79
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-1.25-0.27-0.370.19